185 related articles for article (PubMed ID: 9777974)
41. Influence of platelet-derived growth factor on microcirculation during normal and impaired wound healing.
Uhl E; Rösken F; Sirsjö A; Messmer K
Wound Repair Regen; 2003; 11(5):361-7. PubMed ID: 12950640
[TBL] [Abstract][Full Text] [Related]
42. Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo.
Jin Q; Wei G; Lin Z; Sugai JV; Lynch SE; Ma PX; Giannobile WV
PLoS One; 2008 Mar; 3(3):e1729. PubMed ID: 18320048
[TBL] [Abstract][Full Text] [Related]
43. Extracellular matrix alters PDGF regulation of fibroblast integrins.
Xu J; Clark RA
J Cell Biol; 1996 Jan; 132(1-2):239-49. PubMed ID: 8567727
[TBL] [Abstract][Full Text] [Related]
44. PDGF-BB induced chemotaxis is impaired in aged capillary endothelial cells.
Phillips GD; Stone AM
Mech Ageing Dev; 1994 Mar; 73(3):189-96. PubMed ID: 8057689
[TBL] [Abstract][Full Text] [Related]
45. Platelet-derived growth factor isoforms PDGF-AA, -AB and -BB exert specific effects on collagen gene expression and mitotic activity of cultured human wound fibroblasts.
Lepistö J; Peltonen J; Vähä-Kreula M; Niinikoski J; Laato M
Biochem Biophys Res Commun; 1995 Apr; 209(2):393-9. PubMed ID: 7733905
[TBL] [Abstract][Full Text] [Related]
46. The effect of synthetic alginate sulfate hydrogels with recombinant PDGF-BB on Wound healing.
Babavalian H; Tebyanian H; Latifi AM; Shokrgozar MA; Bonakdar S; Shakeri F
Bratisl Lek Listy; 2018; 119(6):391-396. PubMed ID: 29947241
[TBL] [Abstract][Full Text] [Related]
47. Differential effects of platelet-derived growth factor BB in accelerating wound healing in aged versus young animals: the impact of tissue hypoxia.
Wu L; Brucker M; Gruskin E; Roth SI; Mustoe TA
Plast Reconstr Surg; 1997 Mar; 99(3):815-22; discussion 823-4. PubMed ID: 9047202
[TBL] [Abstract][Full Text] [Related]
48. GM1 does not affect PDGF-BB-stimulated [3H] thymidine incorporation or neuritogenesis in SH-SY5Y cells treated with phosphorothioate oligonucleotides antisense to PDGF-A.
Hynds DL; Kniss D; Yates AJ
Ann N Y Acad Sci; 1998 Jun; 845():412. PubMed ID: 9668381
[No Abstract] [Full Text] [Related]
49. Cost effectiveness of Becaplermin in the treatment of diabetic foot ulcers in four European countries.
Ghatnekar O; Persson U; Willis M; Odegaard K
Pharmacoeconomics; 2001; 19(7):767-78. PubMed ID: 11548912
[TBL] [Abstract][Full Text] [Related]
50. Effect of rhPDGF-BB delivery on mediators of periodontal wound repair.
Cooke JW; Sarment DP; Whitesman LA; Miller SE; Jin Q; Lynch SE; Giannobile WV
Tissue Eng; 2006 Jun; 12(6):1441-50. PubMed ID: 16846342
[TBL] [Abstract][Full Text] [Related]
51. Effect of heparin on human corneal fibroblast proliferation in vitro with and without growth factor stimulation.
Denk PO; Knorr M
Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):342-7. PubMed ID: 10208268
[TBL] [Abstract][Full Text] [Related]
52. Promoting Diabetic Wound Therapy Using Biodegradable rhPDGF-Loaded Nanofibrous Membranes: CONSORT-Compliant Article.
Lee CH; Liu KS; Chang SH; Chen WJ; Hung KC; Liu SJ; Pang JS; Juang JH; Chou CC; Chang PC; Chen YT; Wang FS
Medicine (Baltimore); 2015 Nov; 94(47):e1873. PubMed ID: 26632682
[TBL] [Abstract][Full Text] [Related]
53. Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB.
Pierce GF; Tarpley JE; Allman RM; Goode PS; Serdar CM; Morris B; Mustoe TA; Vande Berg J
Am J Pathol; 1994 Dec; 145(6):1399-410. PubMed ID: 7992843
[TBL] [Abstract][Full Text] [Related]
54. The role of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in orthopaedic bone repair and regeneration.
Friedlaender GE; Lin S; Solchaga LA; Snel LB; Lynch SE
Curr Pharm Des; 2013; 19(19):3384-90. PubMed ID: 23432673
[TBL] [Abstract][Full Text] [Related]
55. [Approval for recombinant growth factor. Since January 2000, patients with diabetic foot ulcers can be treated with the growth factor becaplermin (Regranex), manufactured with genetic technology].
Fruhstorfer B
Internist (Berl); 2000 Jan; 41(1):A38. PubMed ID: 10712088
[No Abstract] [Full Text] [Related]
56. Becaplermin.
Balfour JA; Noble S
BioDrugs; 1999 May; 11(5):359-64. PubMed ID: 18031145
[TBL] [Abstract][Full Text] [Related]
57. Use of becaplermin in the closure of pharyngocutaneous fistulas.
Jakubowicz DM; Smith RV
Head Neck; 2005 May; 27(5):433-8. PubMed ID: 15776464
[TBL] [Abstract][Full Text] [Related]
58. Treatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysis.
Kantor J; Margolis DJ
Dermatol Surg; 2001 Apr; 27(4):347-51. PubMed ID: 11298704
[TBL] [Abstract][Full Text] [Related]
59. Use of topical recombinant human platelet-derived growth factor BB in abdominal wound separation.
Shackelford DP; Fackler E; Hoffman MK; Atkinson S
Am J Obstet Gynecol; 2002 Apr; 186(4):701-4. PubMed ID: 11967494
[TBL] [Abstract][Full Text] [Related]
60. Heparan sulfate upregulates platelet-derived growth factor receptors on human lung fibroblasts.
Malmström J; Westergren-Thorsson G
Glycobiology; 1998 Dec; 8(12):1149-55. PubMed ID: 9858636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
